Tolerance and dose

Gas, Bloating And The First Two Weeks: What The Fiber Tolerance Trials Actually Measured

The tolerance studies that back up a phrase like “expect some gas at first” were run at whole grams — five, ten, sometimes more. A capsule this size holds a fraction of one. That gap is worth sitting with before assuming the trials explain what a capsule does.

By SodaTide Team · Last updated September 27, 2026 · 11 min read · Tolerance and dose

What “well tolerated” meant in the trials

A tolerance trial is not asking whether a fiber works. It is asking what a defined dose of it does to a gut over a defined number of hours, measured on a symptom questionnaire rather than a blood test. Bonnema and colleagues ran exactly that kind of study: twenty-six healthy adults, a randomized double-blind crossover, five separate breakfast challenges — a bagel, cream cheese and orange juice, with either a placebo or one of two inulin fibers stirred through it at 5 g or 10 g. Gastrointestinal symptoms were scored across seven domains at zero, two, four, twenty-four and forty-eight hours after each challenge.

The result was not a flat “fine” or “not fine.” Both inulin fibers mildly increased symptoms relative to placebo. Flatulence was the most frequently reported symptom, followed by bloating. The 10 g dose of oligofructose — the shorter-chain form of the fiber — substantially increased symptoms compared with the control breakfast. The paper's own conclusion draws a specific line: up to 10 g/day of native inulin and up to 5 g/day of oligofructose were well tolerated in healthy young adults. That is a dose ceiling, not a blanket reassurance, and it is a different ceiling for the two forms of the same ingredient family.

Two things are worth pulling out of that design before going further. First, the doses tested were not trace amounts stirred into a capsule; they were grams, delivered once and then tracked for two full days. Second, the questionnaire measured seven domains of symptom — not just flatulence — which is why the paper can say bloating was the second most common complaint rather than lumping everything into one vague category of “GI upset.”

Two fibers, two tolerance profiles

SodaTide's label names two fermentable ingredients that behave differently once bacteria in the colon get to them: chicory root inulin and potato resistant starch. Treating them as interchangeable for tolerance purposes is a mistake the trial literature does not make, and neither should a reader deciding what to expect from a bottle that combines both.

Karalus and colleagues tested this directly. Twenty-two adult women, none of them restrained eaters, worked through a within-subject design comparing four isolated fibers — oligofructose, inulin, soluble corn fiber and resistant wheat starch — each given at 10 g the evening before and 10 g the following morning, folded into a chocolate crisp bar. Every treatment was rated well tolerated overall. But the oligofructose bar stood apart: it produced the greatest rise in breath hydrogen of the four, and the most bloating and flatulence symptoms specifically. Resistant starch, in the same design, on the same volunteers, at the same 10 g dose, did not stand out the same way.

That single comparison does the job a label cannot: it separates “fermentable fiber causes gas” from the more specific and more useful fact that some fermentable fibers cause noticeably more gas than others at matched doses, and inulin-type fructans are consistently on the higher end of that range across the tolerance literature. A review of sixty-eight human feeding studies covering fifteen different low-digestible carbohydrates reached the same broad pattern: effects are dose-related and vary by carbohydrate type, and recommendations for safe intake differ ingredient by ingredient rather than following one universal ceiling.

The probiotic blend is a separate case again, and a harder one to pin down, because the label names no strain and no colony count. The strain-naming problem covered elsewhere on this blog applies here too: without knowing which organisms are in the blend or how many of them survive to the point of swallowing, there is no tolerance trial to match it against, well-tolerated or otherwise.

The dose-response data, side by side

Doses, designs and headline findings read from each paper's own abstract.

Read across that table and a pattern holds regardless of which outcome a given trial was chasing: every one of them delivered its fiber in grams, and every one of them ran for at least several days before or after the dose in question. None of them tested a fraction of a gram delivered once a day inside a capsule, because that is not the question tolerance researchers were funded to ask. The doses in this table exist to define where symptoms start, not to describe what happens well below that line.

The gap a capsule sits inside

A size 0 vegetable capsule holds roughly 400 to 500 mg of powder in total, once the capsule shell itself is set aside. That figure covers everything the label names combined — chicory root inulin, potato resistant starch and the probiotic blend — plus whatever excipients hold the powder together. One capsule a day is therefore under half a gram of everything, against a tolerance literature that starts its lowest tested dose at 2.5 g and runs to 10 g and beyond for a single ingredient.

That is not a small gap. It is roughly an order of magnitude between the smallest dose Bouhnik's dose-response phase tested for one carbohydrate and the total weight of three ingredients combined in a capsule. Held against Bonnema's finding that 5 g of oligofructose was the upper edge of “well tolerated,” a capsule sits at a small fraction of even that gentler threshold.

This site's own FAQ says gas is common in the first week or two and calls it fermentation working as expected. That is a reasonable thing to say about a fermentable fiber in general, and nothing in this article contradicts it. What this article adds is a specific caveat: the trials that established when and how much gas a fermentable carbohydrate produces were run at doses this capsule does not appear to reach, based on the scale printed on the pack rather than a Supplement Facts panel, which the artwork supplied with this product does not include. Anyone who does notice gas in the first fortnight is not wrong to notice it, and anyone who notices nothing is not an outlier against this particular literature either, because the literature was not built to predict outcomes at this dose in the first place. The honest position is that the tolerance trials explain gas at gram-level intakes convincingly and say nothing directly about milligram-level ones.

Individual variability closes some of that gap in practice. Colonic bacterial populations differ substantially between people, and a gut already carrying a large population of gas-producing fermenters can respond more to a small substrate load than a gut that is not. None of the papers cited in this article measured that variable directly at capsule-level doses, so it stays a plausible explanation rather than a demonstrated one, and this site does not present it as more than that.

What the literature says helps, regardless of dose

Even without a trial run at capsule-level doses, the broader tolerance literature converges on a few practical points that do not depend on knowing the exact gram figure, and they line up with what the label itself asks for.

• Take it with food and water. Every tolerance trial in this article delivered its test fiber alongside a meal rather than on an empty stomach; the label's own instruction to take the capsule with an 8 oz glass of water, preferably before a meal, matches that pattern rather than inventing a new one.
• Expect the first exposures to be the most noticeable. Bonnema's design tracked symptoms out to forty-eight hours after a single challenge, which is consistent with gas and bloating clustering around initial or infrequent exposure rather than persisting indefinitely once a routine is established.
• Different fermentable fibers are not interchangeable. Karalus's head-to-head result — oligofructose producing more symptoms than resistant starch at the same dose — is the clearest single reason to expect this bottle's two named fibers to feel different from each other, not just different from nothing.
• Dose-response, not ingredient identity, drives most of the symptom curve. Grabitske's review of sixty-eight studies frames gastrointestinal effects as a function of how much of a low-digestible carbohydrate was consumed, which is the same framing this site uses when discussing chicory inulin and the dose question for effectiveness rather than tolerance.

None of that adds up to a titration schedule for a one-capsule-a-day product, because there is no smaller printed dose to step down to and no gram figure on the artwork to titrate against in the first place. What it does offer is a way to read an early bout of gas or bloating without over-interpreting it: it is consistent with what fermentable fiber does at some dose, and the specific dose inside this capsule is not one the tolerance trials happened to test.

Anyone weighing whether to persist through an uncomfortable first week or two against simply buying a fiber that prints its gram count is really asking the same question this site raises about potato resistant starch in a capsule versus a kitchen: a labelled powder lets a reader match their own experience against a specific number, while a capsule offers convenience at the cost of that comparison. Neither choice is dishonest. Knowing which trade a reader is making is the part worth getting right.

References